A New Filler Might Be Coming in 2017

By ·
A New Filler Might Be Coming in 2017 featured image

2017 may be a few months away, but the New Year is already promising the debut of a new filler.

“There is a new poly-lactic acid filler being launched by DermAvance Pharmaceuticals, which will be indicated for the cosmetic enhancement of the nasolabial folds,” Miami dermatologist S. Manjula Jegasothy, MD, tells us (she is also a clinical investigator for the product). “The FDA filing mentions that it can be reconstituted immediately [this is when the product is mixed with sterile water] before injecting the patient, making it much more convenient regarding scheduling for physician offices. In addition, the recommended reconstitution amount is greater, thereby rendering a better, more full result per vial of product.”

Currently, Sculptra Aesthetic is approved for a similar application—this filler helps gradually replace lost collagen and is indicated for the smile lines (otherwise known as nasolabial folds), marionette lines and chin wrinkles, and it has been shown to last more than two years. Plus, it’s been around for a pretty long time. “I’ve been injecting it for more than 10 years,” says Troy, MI, plastic surgeon Anthony Youn, MD.

You May Also Like: Are Dermal Fillers Reversible?

So…if your next question is, “This sounds great but how long will it take for the FDA to approve a new filler?” Dr. Jegasothy says you won’t have to wait too long. “DermAvance is anticipating a 2017 approval, and because this product has a known profile, the physician adopting phase should be very short. Innovative physicians will be injecting this product immediately after its FDA-approval.”

Stay tuned to NewBeauty.com for more details as they break.

You May Also Like: This New Trick Makes Fillers Last Longer

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.